TAISHO PHARMACEUTICAL HOLDINGS CO.,LTD. 4581Short Interest

No institution currently reports a short position of 0.5% or more in TAISHO PHARMACEUTICAL HOLDINGS CO.,LTD. (4581). The last disclosure was on 2022-05-31 (Integrated Core Strategies (Asia) Pte. Ltd., 0.08%).

TSE 1st Section (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
18 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 1 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2022-02-02
Latest disclosure2022-05-31 (Integrated Core Strategies (Asia) Pte. Ltd., 0.08%)
Reporting institutions1 firms (18 reports)
Peak estimated short interest1.45% (2022-05-27, 1 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 1 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2022-05-31 Integrated Core Strategies (Asia) Pte. Ltd. Position 68,700 shares Ratio 0.08% ▼1.19% −1,013,600 Below 0.5%

Disclosure History 18 in total

Trade date Short seller Position (shares) Ratio Change Note
2022-05-31 Integrated Core Strategies (Asia) Pte. Ltd. Position 68,700 shares Ratio 0.08% ▼1.19% −1,013,600 Below 0.5%
2022-05-30 Integrated Core Strategies (Asia) Pte. Ltd. Position 1,082,300 shares Ratio 1.27% ▼0.18% −158,200 —
2022-05-27 Integrated Core Strategies (Asia) Pte. Ltd. Position 1,240,500 shares Ratio 1.45% ▲0.10% +90,600 —
2022-05-26 Integrated Core Strategies (Asia) Pte. Ltd. Position 1,149,900 shares Ratio 1.35% ▲0.09% +71,700 —
2022-05-25 Integrated Core Strategies (Asia) Pte. Ltd. Position 1,078,200 shares Ratio 1.26% ▲0.15% +128,100 —
2022-05-23 Integrated Core Strategies (Asia) Pte. Ltd. Position 950,100 shares Ratio 1.11% ▲0.10% +84,000 —
2022-05-19 Integrated Core Strategies (Asia) Pte. Ltd. Position 866,100 shares Ratio 1.01% ▲0.10% +87,500 —
2022-05-17 Integrated Core Strategies (Asia) Pte. Ltd. Position 778,600 shares Ratio 0.91% ▲0.08% +64,900 —
2022-05-11 Integrated Core Strategies (Asia) Pte. Ltd. Position 713,700 shares Ratio 0.83% ▲0.13% +117,700 —
2022-05-06 Integrated Core Strategies (Asia) Pte. Ltd. Position 596,000 shares Ratio 0.70% ▲0.09% +70,600 —
2022-05-02 Integrated Core Strategies (Asia) Pte. Ltd. Position 525,400 shares Ratio 0.61% ▲0.03% +30,800 —
2022-04-27 Integrated Core Strategies (Asia) Pte. Ltd. Position 494,600 shares Ratio 0.58% ▼0.10% −89,000 —
2022-04-25 Integrated Core Strategies (Asia) Pte. Ltd. Position 583,600 shares Ratio 0.68% ▼0.03% −21,900 —
2022-04-20 Integrated Core Strategies (Asia) Pte. Ltd. Position 605,500 shares Ratio 0.71% ▲0.09% +76,100 —
2022-04-14 Integrated Core Strategies (Asia) Pte. Ltd. Position 529,400 shares Ratio 0.62% ▲0.12% +97,900 —
2022-04-12 Integrated Core Strategies (Asia) Pte. Ltd. Position 431,500 shares Ratio 0.50% ▲0.08% +16,100 —
2022-02-10 Integrated Core Strategies (Asia) Pte. Ltd. Position 415,400 shares Ratio 0.48% ▼0.04% −28,100 Below 0.5%
2022-02-02 Integrated Core Strategies (Asia) Pte. Ltd. Position 443,500 shares Ratio 0.52% ▲0.09% —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector